Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03305549 · ClinicalTrials.gov registry record · NA
Recovery After Dialysis-Requiring Acute Kidney Injury
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03305549 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 16 participants.
The verdict
NCT03305549, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The Recovery After Dialysis-Requiring Acute Kidney Injury (RAD-AKI) Pilot Study is a 2-arm randomized clinical trial of hospitalized patients with dialysis-requiring acute kidney injury (RAD-AKI), comparing conventional thrice-weekly intermittent hemodialysis dialysis (control) to a "conservative dialysis strategy" in which hemodialysis is not continued unless specific metabolic or clinical indications for RRT are present. The overall hypothesis is that the current practice of thrice-weekly acute intermittent hemodialysis for AKI-D masks evidence of renal recovery and may actually delay or preclude recovery. The primary objective of this pilot study is to assess the safety and feasibility of the proposed intervention and study design.
Interventions
- OTHER Conservative dialysis strategy
- OTHER TIW dialysis strategy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-09-29 |
| Est. Completion | 2019-11-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03305549
The ClinicalTrials.gov registry entry for NCT03305549 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Conservative dialysis strategy is the first listed.
NCT03305549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03305549 about?
NCT03305549 is a clinical study titled "Recovery After Dialysis-Requiring Acute Kidney Injury". The Recovery After Dialysis-Requiring Acute Kidney Injury (RAD-AKI) Pilot Study is a 2-arm randomized clinical trial of hospitalized patients with dialysis-requiring acute kidney injury (RAD-AKI), comparing conventional thrice-weekly intermittent hemodialysis dialysis (control) to a "conservative di...
What is the current status of trial NCT03305549?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2017-09-29. Estimated completion is 2019-11-13.
What interventions are being tested in trial NCT03305549?
The interventions under investigation include: Conservative dialysis strategy (OTHER), TIW dialysis strategy (OTHER).
Who is sponsoring clinical trial NCT03305549?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.